Astal Laboratories Limited (BOM:512600)

Market Cap	3.34B +280.5%
Revenue (ttm)	3.22B +326.0%
Net Income	220.42M +136.4%
EPS	5.26 -34.4%
Shares Out	43.80M
PE Ratio	14.50
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	3,260
Open	76.40
Previous Close	75.80
Day's Range	74.10 - 76.40
52-Week Range	60.45 - 103.20
Beta	-0.46
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 14, 2026

About Astal Laboratories

Astal Laboratories Limited manufactures and sells pharmaceutical intermediates and bulk drugs in India. The company was formerly known as Macro International Limited and changed its name to Astal Laboratories Limited in April 2024. Astal Laboratories Limited was incorporated in 1993 and is headquartered in Jaipur, India. Astal Laboratories Limited operates as a subsidiary of Aceso Research Labs LLP.

• Industry: Short-Term Business Credit Institutions, Except Agricultural
• Founded: 1993
• Country: India
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 512600

Financial Performance

In fiscal year 2026, Astal Laboratories's revenue was 2.47 billion, an increase of 288.52% compared to the previous year's 636.55 million. Earnings were 147.09 million, an increase of 64.81%.

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Sep 11, 2026

Data Sources Report a data error